Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study

BACKGROUND: An extended interval between the two primary doses may reduce the risk of myocarditis/pericarditis after COVID-19 mRNA vaccination. Taiwan has implemented a two-dose regimen with a 12-week interval for adolescents. Here we present nationwide data of myocarditis/pericarditis following COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Wei-Ju, Liu, Yu-Lun, Chang, Chia-Hsuin, Lin, Yen-Ching, Huang, Wei-I, Wu, Li-Chiu, Chen, Shu-Fong, Lin, Yu-Sheng, Hsieh, Yee-Lin, Yang, Chiao-An, Lin, Chiu-Hsiang, Chan, Kim-Wei Arnold, Lee, Ping-Ing, Chuang, Jen-Hsiang, Yang, Chin-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907782/
https://www.ncbi.nlm.nih.gov/pubmed/36804307
http://dx.doi.org/10.1016/j.jmii.2023.01.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907782/
https://www.ncbi.nlm.nih.gov/pubmed/36804307
http://dx.doi.org/10.1016/j.jmii.2023.01.016

Ejemplares similares